Product Description: GW 1929 is an orally active peroxisome proliferator-activated receptor-γ (PPARγ) agonist with a pKi of 8.84 for human PPAR-γ, and pEC50s of 8.56 and 8.27 for human PPAR-γ and murine PPAR-γ, respectively. GW 1929 (hydrochloride) has antidiabetic efficacy and neuroprotective potential[1][2].
Applications: Metabolism-sugar/lipid metabolism
Formula: C30H29N3O4
References: [1]Brown KK, et al. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes. 1999 Jul;48(7):1415-24./[2]Wojtowicz AK, et al. PPAR-γ agonist GW1929 but not antagonist GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells. Neurotox Res. 2014 Apr;25(3):311-22.
CAS Number: 196808-24-9
Molecular Weight: 495.57
Compound Purity: 99.93
Research Area: Metabolic Disease; Neurological Disease
Solubility: DMSO : ≥ 35 mg/mL
Target: PPAR
English
Deutsch
